Ocrelizumab May Reduce Disability Progression in People With Primary Progressive MSOctober 6, 2015Multiple Sclerosis
Novel Peptide Shows Promise for a Broad Spectrum of Inflammation-Related DisordersSeptember 30, 2015Multiple Sclerosis